Home Cart Sign in  
Chemical Structure| 2937327-93-8 Chemical Structure| 2937327-93-8

Structure of BI-2865
CAS No.: 2937327-93-8

Chemical Structure| 2937327-93-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BI-2865

CAS No. :2937327-93-8
Formula : C23H27N7O2S
M.W : 465.57
SMILES Code : N#CC1=C(N)SC2=C1[C@](C3=NC(C4=NC=CC(O[C@H]([C@H]5N(C)CCC5)C)=N4)=NO3)(C)CCC2
MDL No. :N/A

Safety of BI-2865

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293/ABCB1 cells 2 µM, 4 µM, 8 µM 72 h BI-2865 significantly enhanced the response of P-gp-driven MDR cancer cells to chemotherapy drugs including paclitaxel and doxorubicin. Cell Commun Signal. 2024 Jun 13;22(1):325
MCF7/adr cells 2 µM, 4 µM, 8 µM 72 h BI-2865 significantly enhanced the response of P-gp-driven MDR cancer cells to chemotherapy drugs including doxorubicin. Cell Commun Signal. 2024 Jun 13;22(1):325
KBv200 cells 2 µM, 4 µM, 8 µM 72 h BI-2865 significantly enhanced the response of P-gp-driven MDR cancer cells to chemotherapy drugs including paclitaxel, vincristine, and doxorubicin, while no such effect was observed in their parental sensitive cells and BCRP or MRP1-driven MDR cells. Cell Commun Signal. 2024 Jun 13;22(1):325

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/C nude mice KBv200 xenograft model Oral 30 mg/kg Once every two days BI-2865 effectively improved the anti-tumor action of paclitaxel without toxic injury. Cell Commun Signal. 2024 Jun 13;22(1):325

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.15mL

0.43mL

0.21mL

10.74mL

2.15mL

1.07mL

21.48mL

4.30mL

2.15mL

 

Historical Records